Junhua Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Junhua Xie has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Shaoping Nie
Nanchang University
11 shared publications Qiqiong Li
State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China
10 shared publicationsXinke Nie
State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China
8 shared publicationsXinyang Chen
8 shared publications- Qiqiong Li
Nanchang University
7 shared publications Wanyu Zhang
State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China
6 shared publications
Latest Publications
- 13 November 2026
- Published by Elsevier in Food Bioscience
- Vol. 86
Interindividual variations and sugar moiety structures shape the microbial biotransformation of quercetin-3-O-monoglycosides
- 13 November 2026
- Published by Elsevier in Food Bioscience
- Vol. 86
Interindividual variations and sugar moiety structures shape the microbial biotransformation of quercetin-3-O-monoglycosides
- Open Access
- 9 October 2026
- Published by Springer Nature in npj Science of Food
Four dietary flavonoids differentially modulate the gut microbiota–barrier interaction against colitis-driven cognitive deficits
- 9 October 2026
- Published by Springer Nature in npj Science of Food
Open AccessFour dietary flavonoids differentially modulate the gut microbiota–barrier interaction against colitis-driven cognitive deficits
- 21 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
Outer Membrane Protein A from Escherichia coli Nissle 1917 Vesicles Alleviates Colon Inflammation by Modulating Specific Inflammatory Signaling Pathway
Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal condition. Probiotic-derived outer membrane vesicles (OMVs) have emerged as a promising postbiotic strategy for IBD. Here, we evaluated the protective effects of Escherichia coli Nissle 1917 (EcN)-derived OMVs in a DSS-induced colitis mouse model using a pretreatment regimen. EcN OMVs attenuated colitis by improving the intestinal barrier and suppressing inflammatory responses, and this anti-inflammatory effect is largely attributed to outer membrane protein A (OmpA). OmpA-carrying EcN OMVs were associated with inhibition of excessive inflammation through a mechanism associated with suppression of TLR4/NF-κB signaling activation. Our work identifies potential mechanisms and key active components by which EcN OMVs may prevent intestinal inflammation. These results underscore the promise of EcN OMVs as functional food ingredients or dietary supplements for gut health maintenance.
- 21 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
Outer Membrane Protein A from Escherichia coli Nissle 1917 Vesicles Alleviates Colon Inflammation by Modulating Specific Inflammatory Signaling Pathway
Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal condition. Probiotic-derived outer membrane vesicles (OMVs) have emerged as a promising postbiotic strategy for IBD. Here, we evaluated the protective effects of Escherichia coli Nissle 1917 (EcN)-derived OMVs in a DSS-induced colitis mouse model using a pretreatment regimen. EcN OMVs attenuated colitis by improving the intestinal barrier and suppressing inflammatory responses, and this anti-inflammatory effect is largely attributed to outer membrane protein A (OmpA). OmpA-carrying EcN OMVs were associated with inhibition of excessive inflammation through a mechanism associated with suppression of TLR4/NF-κB signaling activation. Our work identifies potential mechanisms and key active components by which EcN OMVs may prevent intestinal inflammation. These results underscore the promise of EcN OMVs as functional food ingredients or dietary supplements for gut health maintenance.
- 20 August 2026
- Published by Elsevier in Food Bioscience
- Vol. 84
Beyond the gut: The role of Akkermansia muciniphila in neurological health and its application in functional foods
- 20 August 2026
- Published by Elsevier in Food Bioscience
- Vol. 84
Beyond the gut: The role of Akkermansia muciniphila in neurological health and its application in functional foods
- 18 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (33) , 26290-26302
Functional Specialization of Cellular and Extracellular Fractions of Bacteroides thetaiotaomicron Contributes to Glycan Utilization
Bacteroides thetaiotaomicron (Bt) degrades dietary glycans via carbohydrate-active enzymes (CAZymes), but their spatial distribution and functional coordination remain unclear. In this study, we characterized the “labor division” during glycan degradation across four bacterial fractions: cytoplasm, outer membrane, extracellular vesicles, and supernatant. All fractions displayed hydrolytic activity. Proteomic analysis identified abundant glycoside hydrolases, mainly GH32 enzymes encoded by PUL22, and their components varied greatly. Untargeted metabolomics identified 45 shared differential metabolites (e.g., carbohydrates and short-chain fatty acids), indicating distinct hydrolytic capacities among fractions. Notably, cross-feeding experiments confirmed that Bt EVs-mediated degradation can support the growth of recipient bacteria. Collectively, our results reveal a synergistic multicomponent strategy for glycan degradation in Bacteroides, offering new insights into glycan utilization and laying a foundation for developing postbiotics and functional microbial products.
- 18 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (33) , 26290-26302
Functional Specialization of Cellular and Extracellular Fractions of Bacteroides thetaiotaomicron Contributes to Glycan Utilization
Bacteroides thetaiotaomicron (Bt) degrades dietary glycans via carbohydrate-active enzymes (CAZymes), but their spatial distribution and functional coordination remain unclear. In this study, we characterized the “labor division” during glycan degradation across four bacterial fractions: cytoplasm, outer membrane, extracellular vesicles, and supernatant. All fractions displayed hydrolytic activity. Proteomic analysis identified abundant glycoside hydrolases, mainly GH32 enzymes encoded by PUL22, and their components varied greatly. Untargeted metabolomics identified 45 shared differential metabolites (e.g., carbohydrates and short-chain fatty acids), indicating distinct hydrolytic capacities among fractions. Notably, cross-feeding experiments confirmed that Bt EVs-mediated degradation can support the growth of recipient bacteria. Collectively, our results reveal a synergistic multicomponent strategy for glycan degradation in Bacteroides, offering new insights into glycan utilization and laying a foundation for developing postbiotics and functional microbial products.
- Open Access
- 23 May 2026
- Published by Springer Nature in npj Science of Food
- Vol. 10 (1)
Faecalibacterium prausnitzii-derived extracellular vesicles ameliorate experimental colitis through regulating barrier immunity and gut microbiota
Ulcerative colitis (UC) is closely linked to intestinal barrier dysfunction and gut dysbiosis. Bacterial extracellular vesicles (bEVs) act as key mediators of bacteria-host crosstalk, with great potential in regulating host health. Recent studies have shown that EVs derived from gut commensal bacteria offer therapeutic advantages in treating UC. Herein, we explored the therapeutic effect of Faecalibacterium prausnitzii-derived EVs (PEVs) in DSS-induced colitis mice. Results showed PEVs significantly improved intestinal barrier damage, restored Th17/Treg balance and alleviated gut dysbiosis. Further fecal microbiota transplantation (FMT) confirmed that feces from PEVs-treated mice transferred beneficial effects to recipient colitis mice. Collectively, our findings indicate that commensal gut microbiota-derived nanovesicles have the potential to serve as candidates for UC treatment.
- 23 May 2026
- Published by Springer Nature in npj Science of Food
- Vol. 10 (1)
Open AccessFaecalibacterium prausnitzii-derived extracellular vesicles ameliorate experimental colitis through regulating barrier immunity and gut microbiota
Ulcerative colitis (UC) is closely linked to intestinal barrier dysfunction and gut dysbiosis. Bacterial extracellular vesicles (bEVs) act as key mediators of bacteria-host crosstalk, with great potential in regulating host health. Recent studies have shown that EVs derived from gut commensal bacteria offer therapeutic advantages in treating UC. Herein, we explored the therapeutic effect of Faecalibacterium prausnitzii-derived EVs (PEVs) in DSS-induced colitis mice. Results showed PEVs significantly improved intestinal barrier damage, restored Th17/Treg balance and alleviated gut dysbiosis. Further fecal microbiota transplantation (FMT) confirmed that feces from PEVs-treated mice transferred beneficial effects to recipient colitis mice. Collectively, our findings indicate that commensal gut microbiota-derived nanovesicles have the potential to serve as candidates for UC treatment.
- 20 March 2026
- Published by Elsevier in Food Bioscience
- Vol. 79
Food-derived extracellular vesicles: novel dietary regulators for metabolic homeostasis
- 20 March 2026
- Published by Elsevier in Food Bioscience
- Vol. 79
Food-derived extracellular vesicles: novel dietary regulators for metabolic homeostasis
- Top Cited Papers
- 10 March 2026
- Published by Elsevier in Food Bioscience
- Vol. 79
Bacterial extracellular vesicles as next-generation postbiotic for inflammatory bowel disease
- 10 March 2026
- Published by Elsevier in Food Bioscience
- Vol. 79
Top Cited PapersBacterial extracellular vesicles as next-generation postbiotic for inflammatory bowel disease
- 29 January 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale Horizons
- Vol. 11 (5) , 1215-1238
Advances in extracellular vesicle research: tools and techniques
Overview of the techniques used for isolation, labeling, imaging and characterization of EVs.
- 29 January 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale Horizons
- Vol. 11 (5) , 1215-1238
Advances in extracellular vesicle research: tools and techniques
Overview of the techniques used for isolation, labeling, imaging and characterization of EVs.